This inventor holds 5 USPTO granted patents. Top assignees: Abbott Laboratories Corporation, Abbott Gmbh & Co Kg, Basf Aktiengesellschaft. Active years: 2002-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 4,189 
1 out of 140 
1 out of 10,816 
Years Active: 2002-2004
Title: The Innovative Mind of Hans Wolfgang Höffken
Introduction
Hans Wolfgang Höffken is a notable inventor based in Ludwigshafen, Germany. With an impressive portfolio consisting of five patents, Höffken has made significant contributions to the field of pharmaceuticals, particularly through his work on thrombin inhibitors. His research and innovations have the potential to transform the treatment of various medical conditions.
Latest Patents
Höffken's latest patents focus on thrombin inhibitors, specifically novel five-membered heterocyclic amidines. These compounds have been developed for their properties as competitive inhibitors of trypsin-like serine proteases, especially thrombin and kininogenases such as kallikrein. Furthermore, his patents outline pharmaceutical compositions that contain these compounds as active ingredients, showcasing their utility as thrombin inhibitors, anticoagulants, and anti-inflammatory agents.
Career Highlights
Throughout his career, Höffken has had the opportunity to work with esteemed organizations, including Abbott Laboratories Corporation and Abbott GmbH & Co. KG. His experience within these companies has allowed him to refine his expertise in the pharmaceutical sector and contribute to the development of cutting-edge medical therapies.
Collaborations
In his innovative journey, Höffken has collaborated with prominent professionals in the field, including Helmut Mack and Werner Seitz. These partnerships have facilitated knowledge sharing and have been instrumental in advancing his research and patent development.
Conclusion
Hans Wolfgang Höffken's dedication to innovation in the pharmaceutical industry is evident through his groundbreaking patents and collaborations. His work in developing thrombin inhibitors not only demonstrates his technical prowess but also highlights his commitment to enhancing medical therapies. As the landscape of pharmaceuticals continues to evolve, Höffken's contributions will remain significant in the ongoing search for effective medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile